Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    • News

  • Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    • News

  • EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    • News

  • RocketDNA Secures Major Aerial Tech Contract with Vault Minerals at WA Gold Site
    RocketDNA Secures Major Aerial Tech Contract with Vault Minerals at WA Gold Site
    • News

  • BirdDog Boosts Buy-Back Offer by 40% Ahead of ASX Delisting Vote
    BirdDog Boosts Buy-Back Offer by 40% Ahead of ASX Delisting Vote
    • News

  • AML3D Launches High-Tech U.S. Facility to Power Submarine Supply Chain
    AML3D Launches High-Tech U.S. Facility to Power Submarine Supply Chain
    • News

  • Vection Enters $520K Agritech Deal to Build AI-Powered Farming Robot
    Vection Enters $520K Agritech Deal to Build AI-Powered Farming Robot
    • News

  • Unith Achieves Strong Growth in Platform Usage and Strategic Partnerships
    Unith Achieves Strong Growth in Platform Usage and Strategic Partnerships
    • News

  • FBR and Samsung Heavy Industries Execute Engineering Service Agreement for Shipbuilding Automation Project
    FBR and Samsung Heavy Industries Execute Engineering Service Agreement for Shipbuilding Automation Project
    • News

  • Bioxyne Lifts FY2025 Revenue Forecast as Psychedelics and Pharma Push Gains Pace
    Bioxyne Lifts FY2025 Revenue Forecast as Psychedelics and Pharma Push Gains Pace
    • News

Ostreophiles, get your shucking knives ready- Angel Seafood increases stock by 94%

  • In News
  • October 26, 2021
  • Samantha Freidin
Ostreophiles, get your shucking knives ready- Angel Seafood increases stock by 94%

Charles Dickens wrote “Poverty and oysters always seem to go together”. 

Yep, oysters used to be a poor man’s food. A cheap source of protein often supplementary to beef. 

Thanks to overharvesting in the 20th century the bivalves have since become a pricey delicacy, pulling profits for growers like Angel Seafood (ASX: AS1), the Southern Hemisphere’s largest producer of certified organic and sustainable pacific oysters. 

The Company has enjoyed a productive quarter, delivering record revenue of $2.1 million, up 5% on the prior corresponding period. There has been an increase in the average price of oysters to 80 cents each (up from 75 cents in Q3) ahead of peak season demand as food services return to Victoria and New South Wales. 

The Company’s farms remain well stocked, with biomass increasing by 94% to 496 tonnes, all but guaranteeing continued supply throughout the peak season, covering the festive summer period as well as Chinese New Year and Valentine’s Day. The Company expects annual sales to increase by 10-15% despite no further investment in assets. 

Freight costs for export remain a challenge for the Company who recommenced exports during the quarter. Overseas sales only accounted for 5% of sales for the period however Angel hopes to see this rise as freight systems and logistics catch their breath post- COVID. 

In an effort to expand their direct to consumer service the Company launched Halo Club- a subscription membership where customers receive 3 dozen Coffin Bay oysters and a range of restaurant quality dressings and sauces (plus an exclusive shucking set in the first month!). The Club is expected to generate a 30-50% price premium on comparable wholesale prices once running on a commercial scale, providing the Business with a high-value, recurring revenue stream. 

The Company remains well funded with $3 million in the bank and operating outflows for the quarter coming in at $175k. 

Angel CEO, Founder and ostreophile Zac Halman said: “Despite restrictive trading conditions in NSW, ACT and Victoria throughout much of the period, Angel has produced a record September quarter revenue result. Our ability to improve stock profiles, minimise mortality rates, and sell our oysters into our growing channels at improved prices has helped contribute to this record result. “

“September trading conditions in particular, showed promising signs of a resurgence in oyster demand ahead of the festive and summer season; sales increased 66% when compared to August.

“Good growth conditions have allowed us to increase our biomass considerably while increasing the average size of our oysters. We hold a very strong stock position as we move into Q4, placing us well to have sufficient supply on hand and ready to be deployed for the peak season as much of the economy reopens and to service the increasingly growing retail channel.”

  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022
  •  
  •  
  •  
  •  
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.